IP Library Granted Patent US 12,226,646
Granted Patent B2
US 12,226,646 · App. 17/351,045 · Granted Feb 18, 2025

Wearable cardioverter defibrillator (WCD) system having main UI that conveys message and peripheral device that amplifies the message

Inventors: Zoie Engman (Kirkland, WA); Aaron Piazza (Lake Forest Park, WA); Christoffer Peter Hart Hansen (Seattle, WA); David P. Finch (Bothell, WA); Laura M. Gustavson (Redmond, WA); Erik L. Schneider (Kirkland, WA); Erick Roane (Bellevue, WA); Amanda K. Hall (Seattle, WA)
Assignee: West Affum Holdings DAC
A61N1/3993A61B5/0205A61B5/6804A61N1/046A61N1/0484A61N1/3904A61N1/3968A61N1/3975G06F3/1454A61B5/0002A61B5/024A61B5/026A61B5/029A61B5/0816A61B5/11A61B5/1455A61B5/363A61B5/7275A61B7/003A61B7/04G08B3/10G08B6/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,226,646
App. No.
17/351,045
Granted
Feb 18, 2025
Kind
B2
Abstract

In embodiments, a Wearable Cardiac Defibrillator (WCD) system is configured to be worn by an ambulatory patient. The WCD system includes a main user interface (UI) output device that can output an image, sound or vibration as a main message about a condition of the patient or the WCD system. The patient may further carry a peripheral device that can also output an image, sound or vibration as a peripheral message about the condition. The peripheral message may mirror the main message at least in part, amplify it, and so on. The availability of the peripheral message provides the patient with the opportunity to better perceive the main message, and the flexibility to receive and react to it discreetly, learn more about the condition, and so on.

Claims (73)

1. In combination, main components of a wearable cardioverter defibrillator (WCD) system configured to be worn by an ambulatory patient and a peripheral device that is configured to be carried by the ambulatory patient, wherein:

the main components comprise:

an electrode;

a support structure configured to be worn by the ambulatory patient to maintain the electrode on a body of the ambulatory patient;

an energy storage module configured to store an electrical charge, and to discharge at least some of the stored electrical charge via the electrode;

a main housing;

a main user interface (UI) output device located at least partly within the main housing;

a main communication module; and

a main processor configured to:

receive an input about a condition, the condition being about one of the ambulatory patient, one of the main components of the WCD system, or both;

transmit a main driving signal to the main UI output device;

cause, responsive to the received input and the main driving signal, the main UI output device to output a main human-perceptible indication (HPI), the main HPI being about the condition;

transmit a main notification signal to the main communication module; and

cause, responsive to the received input and the main notification signal, the main communication module to transmit an amplification signal, the amplification signal encoding a message about the condition; and

the peripheral device comprises:

a peripheral housing distinct from the main housing;

a peripheral communication module (PCM) located at least partly within the peripheral housing, wherein the PCM is configured to, responsive to receiving the transmitted amplification signal with the encoded message, amplify the encoded message; and

a peripheral UI output device configured, responsive to the PCM amplifying the encoded message, to output a peripheral HPI, the peripheral HPI being about the condition.

2. The combination of claim 1 , wherein the energy storage module is located within the main housing.

3. The combination of claim 1 , wherein the PCM includes an antenna, and the amplification signal is transmitted wirelessly.

4. The combination of claim 1 , wherein the peripheral device is a component of the WCD system.

5. The combination of claim 1 , wherein the peripheral device is a general purpose machine running a software application.

6. The combination of claim 1 , wherein the peripheral device further comprises:

a peripheral processor configured, responsive to the PCM receiving the amplification signal, to decode the encoded message and drive the peripheral UI output device to output the peripheral HPI.

7. The combination of claim 1 , wherein the peripheral HPI is output concurrently with the main HPI.

8. The combination of claim 1 , wherein the main components further comprise a sensor configured to monitor a patient parameter of the ambulatory patient, and the condition includes a value of the patient parameter.

9. The combination of claim 1 , wherein the main components further comprise a sensor configured to monitor an operational parameter of the WCD system, and the condition includes a value of the operational parameter.

10. The combination of claim 1 , wherein the main components further comprise a sensor configured to monitor an operational parameter of the WCD system, and the condition includes that a value of the operational parameter is beyond a threshold.

11. The combination of claim 1 , wherein the main components further comprise:

a battery; and

a charge monitor configured to monitor a state of charge of the battery, the condition includes a value for the state of charge.

12. The combination of claim 1 , wherein the main components further comprise a wear monitor configured to:

determine whether or not the support structure is worn by the ambulatory patient in a certain way; and

output a wear confirmation, responsive to determining that the support structure is worn by the ambulatory patient in the certain way, wherein the condition includes an indication of the wear confirmation.

13. The combination of claim 1 , wherein:

the main HPI includes a sound, wherein the main UI output device includes a main speaker configured to emit the sound; and

the peripheral HPI includes an image, wherein the peripheral UI output device includes a peripheral screen configured to display the image.

14. The combination of claim 1 , wherein:

the main HPI includes a vibration, wherein the main UI output device includes a main vibration device configured to emit the vibration; and

the peripheral HPI includes an image, wherein the peripheral UI output device includes a peripheral screen configured to display the image.

15. The combination of claim 1 , wherein the peripheral HPI includes a sound, and wherein the peripheral UI output device includes a peripheral speaker configured to emit the sound.

16. The combination of claim 1 , wherein the peripheral HPI includes a vibration, and the peripheral UI output device includes a peripheral vibration device configured to generate the vibration.

17. The combination of claim 1 , wherein:

the main HPI includes a main image, wherein the main UI output device includes a main screen configured to display the main image; and

the peripheral HPI includes a peripheral image, wherein the peripheral UI output device includes a peripheral screen configured to display the peripheral image.

18. The combination of claim 17 , wherein the peripheral image includes the entire main image.

19. The combination of claim 17 , wherein the peripheral image includes a second image that is not included in the main image.

20. The combination of claim 17 , wherein the peripheral image includes an aspect of the main image, and the aspect of the main image as displayed on the peripheral screen has at least 24% larger area than as displayed on the main screen.

21. The combination of claim 17 , wherein the peripheral image includes an aspect of the main image.

22. The combination of claim 17 , wherein the peripheral image includes text that is not included in the main image.

23. The combination of claim 17 , wherein the peripheral image has a first portion and a second portion, and the peripheral UI output device includes a screen configured to initially display the first portion but not the second portion, and then to display the second portion.

24. The combination of claim 23 , wherein the peripheral UI output device includes a touchscreen configured to display the second portion responsive to the touchscreen being touched.

25. The combination of claim 23 , wherein the first portion includes a link, and the peripheral UI output device includes a touchscreen configured to display the second portion responsive to the touchscreen being touched at the link.

26. The combination of claim 1 , wherein the main HPI being about the condition comprises the main HPI including an indication of one or more of:

a value of a patient parameter monitored by a sensor that monitors the patient parameter of the ambulatory patient;

a value of an operational parameter monitored by a sensor that monitors the operational parameter of the WCD system;

a value of an operational parameter exceeding a threshold monitored by the sensor—that monitors the operational parameter of the WCD system is beyond the threshold; and

a value of a state of charge of a battery of the WCD system.

27. A wearable cardioverter defibrillator (WCD) system for treating a patient during a medical event, the WCD system comprising:

a medical treatment device configured to monitor and provide treatment to the patient, wherein the medical treatment device comprises:

at least one physiological sensor input configured to generate physiological signals corresponding to the patient;

a medical treatment device screen for presenting medical information based on the generated physiological signals; and

at least one first processor operably coupled with the at least one physiological sensor input, and the medical treatment device screen, wherein the at least one first processor is configured to:

receive and process the physiological signals corresponding to the patient;

generate medical data based on the processed physiological signals;

display, on the medical treatment device screen in a first display format, case information comprising physiological information rendered from the generated medical data; and

transmit the case information and the generated medical data to another device; and

a companion device communicatively coupled to the medical treatment device to receive the case information and the generated medical data, wherein the companion device comprises:

a device interface having a display screen configured to allow a user to input one or more instructions for the medical treatment device during the medical event; and

at least one second processor operably coupled with the device interface, wherein the at least one second processor is configured to:

process the case information and the generated medical data received from the medical treatment device;

display, at the device interface in a second display format, a real time device view of the case information comprising the physiological information as displayed on the medical treatment device screen, wherein the second display format provides a visual reproduction of the first display format; and

transmit, responsive to detecting at least one user input at the device interface, one or more instruction signals to the medical treatment device.

Assignments (10)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 14, 2025
From: PHYSIO-CONTROL, INC.
To: WEST AFFUM HOLDINGS CORP.
Reel/Frame 069864/0382 →
SECURITY AGREEMENT Recorded Oct 4, 2023
From: WEST AFFUM HOLDINGS DESIGNATED ACTIVITY COMPANY
To: PERCEPTIVE CREDIT HOLDINGS IV, LP
Reel/Frame 065116/0049 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 26, 2022
From: HALL, AMANDA K.
To: PHYSIO-CONTROL DEVELOPMENT CO., LLC
Reel/Frame 060621/0703 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2022
From: PIAZZA, AARON; HART HANSEN, CHRISTOFFER PETER
To: TACTILE, INC.
Reel/Frame 060359/0555 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2022
From: WEST AFFUM HOLDINGS CORP.
To: WEST AFFUM HOLDINGS DAC
Reel/Frame 060389/0694 →
CORRECTIVE ASSIGNMENT TO CORRECT THE SPELLING OF ASSIGNOR LAURA M. GUSTAVSON'S LAST NAME PREVIOUSLY RECORDED ON REEL 057818 FRAME 0427. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Nov 8, 2021
From: ENGMAN, ZOIE; FINCH, DAVID P.; GUSTAVSON, LAURA M.; SCHNEIDER, ERIK L.; ROANE, ERICK
To: PHYSIO-CONTROL DEVELOPMENT CO., LLC
Reel/Frame 058054/0255 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2021
From: TACTILE, INC.
To: PHYSIO-CONTROL, INC.
Reel/Frame 057899/0095 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2021
From: PHYSIO-CONTROL DEVELOPMENT CO., LLC
To: WEST AFFUM HOLDINGS CORP.
Reel/Frame 057818/0520 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2021
From: ENGMAN, ZOIE; FINCH, DAVID P.; GUSTAFSON, LAURA M.; SCHNEIDER, ERIK L.; ROANE, ERICK
To: PHYSIO-CONTROL DEVELOPMENT CO., LLC
Reel/Frame 057818/0427 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 18, 2021
From: PIAZZA, AARON; HART HANSEN, CHRISTOFFER PETER; HALL, AMANDA K.
To: STRYKER CORPORATION
Reel/Frame 057818/0222 →
Continuity (3)
Continuation 16283342 · Feb 22, 2019
Provisional Application 62637296 · Mar 1, 2018
Related Publication 20210308475A1 · Oct 7, 2021
References Cited (209)
US 3724355A · Busch et al. · 1973 [cited by applicant]
US 3724455A · Unger · 1973 [cited by applicant]
US 4583524A · Hutchins · 1986 [cited by applicant]
US 4619265A · Morgan et al. · 1986 [cited by applicant]
US 4666432A · McNeish et al. · 1987 [cited by applicant]
US 4698848A · Buckley · 1987 [cited by applicant]
US 4928690A · Heilman et al. · 1990 [cited by applicant]
US 4955381A · Way et al. · 1990 [cited by applicant]
US 5078134A · Heilman et al. · 1992 [cited by applicant]
US 5228449A · Christ et al. · 1993 [cited by applicant]
US 5348008A · Bornn et al. · 1994 [cited by applicant]
US 5353793A · Bornn · 1994 [cited by applicant]
US RE34800E · Hutchins · 1994 [cited by applicant]
US 5394892A · Kenny et al. · 1995 [cited by applicant]
US 5405362A · Kramer et al. · 1995 [cited by applicant]
US 5429593A · Matory · 1995 [cited by applicant]
US 5474574A · Payne et al. · 1995 [cited by applicant]
US 5618208A · Crouse et al. · 1997 [cited by applicant]
US 5662690A · Cole et al. · 1997 [cited by applicant]
US 5708978A · Johnsrud · 1998 [cited by applicant]
US 5741306A · Glegyak et al. · 1998 [cited by applicant]
US 5782878A · Morgan et al. · 1998 [cited by applicant]
US 5792204A · Snell · 1998 [cited by applicant]
US 5902249A · Lyster · 1999 [cited by applicant]
US 5913685A · Hutchins · 1999 [cited by applicant]
US 5944669A · Kaib · 1999 [cited by applicant]
US 6047203A · Sackner et al. · 2000 [cited by applicant]
US 6065154A · Hulings et al. · 2000 [cited by applicant]
US 6108197A · Janik · 2000 [cited by applicant]
US 6148233A · Owen et al. · 2000 [cited by applicant]
US 6201992B1 · Freeman · 2001 [cited by applicant]
US 6263238B1 · Brewer et al. · 2001 [cited by applicant]
US 6280461B1 · Glegyak et al. · 2001 [cited by applicant]
US 6287328B1 · Snyder et al. · 2001 [cited by applicant]
US 6304780B1 · Owen et al. · 2001 [cited by applicant]
US 6319011B1 · Motti et al. · 2001 [cited by applicant]
US 6334070B1 · Nova et al. · 2001 [cited by applicant]
US 6356785B1 · Snyder et al. · 2002 [cited by applicant]
US 6427083B1 · Owen et al. · 2002 [cited by applicant]
US 6437083B1 · Brack et al. · 2002 [cited by applicant]
US 6450942B1 · Lapanashvili et al. · 2002 [cited by applicant]
US 6529875B1 · Nakajima et al. · 2003 [cited by applicant]
US 6546285B1 · Owen et al. · 2003 [cited by applicant]
US 6671545B2 · Fincke · 2003 [cited by applicant]
US 6681003B2 · Linder et al. · 2004 [cited by applicant]
US 6762917B1 · Verbiest et al. · 2004 [cited by applicant]
US 7065401B2 · Worden · 2006 [cited by applicant]
US 7099715B2 · Korzinov et al. · 2006 [cited by applicant]
US 7212850B2 · Prystowsky et al. · 2007 [cited by applicant]
US 7559902B2 · Ting et al. · 2009 [cited by applicant]
US 7587237B2 · Korzinov et al. · 2009 [cited by applicant]
US 7753759B2 · Pintor et al. · 2010 [cited by applicant]
US 7865238B2 · Brink · 2011 [cited by applicant]
US 7870761B2 · Valentine et al. · 2011 [cited by applicant]
US 7907996B2 · Prystowsky et al. · 2011 [cited by applicant]
US 7941207B2 · Korzinov · 2011 [cited by applicant]
US 7974689B2 · Volpe et al. · 2011 [cited by applicant]
US 8135462B2 · Owen et al. · 2012 [cited by applicant]
US 8140154B2 · Donnelly et al. · 2012 [cited by applicant]
US 8369944B2 · Macho et al. · 2013 [cited by applicant]
US 8527028B2 · Kurzweil et al. · 2013 [cited by applicant]
US 8548557B2 · Garstka et al. · 2013 [cited by applicant]
US 8560044B2 · Kurzweil et al. · 2013 [cited by applicant]
US 8615295B2 · Savage et al. · 2013 [cited by applicant]
US 8644925B2 · Volpe et al. · 2014 [cited by applicant]
US 8676313B2 · Volpe et al. · 2014 [cited by applicant]
US 8706255B2 · Phillips et al. · 2014 [cited by applicant]
US 8742349B2 · Urbon et al. · 2014 [cited by applicant]
US 8897860B2 · Volpe et al. · 2014 [cited by applicant]
US 8904214B2 · Volpe et al. · 2014 [cited by applicant]
US 8965500B2 · Macho et al. · 2015 [cited by applicant]
US 9008801B2 · Kaib et al. · 2015 [cited by applicant]
US 9084583B2 · Mazar et al. · 2015 [cited by applicant]
US 9089685B2 · Sullivan et al. · 2015 [cited by applicant]
US 9119547B2 · Cazares et al. · 2015 [cited by applicant]
US 9131901B2 · Volpe et al. · 2015 [cited by applicant]
US 9132267B2 · Kaib · 2015 [cited by applicant]
US 9265432B2 · Warren et al. · 2016 [cited by applicant]
US 9345898B2 · Piha et al. · 2016 [cited by applicant]
US 9408548B2 · Volpe et al. · 2016 [cited by applicant]
US 9445719B2 · Libbus et al. · 2016 [cited by applicant]
US 9454219B2 · Volpe et al. · 2016 [cited by applicant]
US 9579020B2 · Libbus et al. · 2017 [cited by applicant]
US 9592403B2 · Sullivan · 2017 [cited by applicant]
US 9598799B2 · Shoshani et al. · 2017 [cited by applicant]
US 9675804B2 · Whiting et al. · 2017 [cited by applicant]
US 9724008B2 · Sullivan et al. · 2017 [cited by applicant]
US 9757576B2 · Sullivan et al. · 2017 [cited by applicant]
US 9878171B2 · Kaib · 2018 [cited by applicant]
US 9895105B2 · Romem · 2018 [cited by applicant]
US 9901741B2 · Chapman et al. · 2018 [cited by applicant]
US RE46926E · Bly et al. · 2018 [cited by applicant]
US 10016613B2 · Kavounas · 2018 [cited by applicant]
US 10076656B2 · Dar et al. · 2018 [cited by applicant]
US 10192387B2 · Brinig et al. · 2019 [cited by applicant]
US 10307133B2 · Kaib · 2019 [cited by applicant]
US 10463867B2 · Kaib et al. · 2019 [cited by applicant]
US 10589110B2 · Oskin et al. · 2020 [cited by applicant]
US 10599814B2 · Landrum et al. · 2020 [cited by applicant]
US 10617881B2 · Pavel et al. · 2020 [cited by applicant]
US 11040214B2 · Engman · 2021 [cited by examiner]
US 20020181680A1 · Linder et al. · 2002 [cited by applicant]
US 20030158593A1 · Heilman et al. · 2003 [cited by applicant]
US 20050107833A1 · Freeman et al. · 2005 [cited by applicant]
US 20050107834A1 · Freeman et al. · 2005 [cited by applicant]
US 20060173499A1 · Hampton et al. · 2006 [cited by applicant]
US 20080312709A1 · Vollpe et al. · 2008 [cited by applicant]
US 20090005827A1 · Weintraub et al. · 2009 [cited by applicant]
US 20100007413A1 · Herleikson · 2010 [cited by applicant]
US 20100298899A1 · Donnelly et al. · 2010 [cited by applicant]
US 20110022105A9 · Owen et al. · 2011 [cited by applicant]
US 20110288604A1 · Kaib et al. · 2011 [cited by applicant]
US 20110288605A1 · Kaib et al. · 2011 [cited by applicant]
US 20120112903A1 · Kaib et al. · 2012 [cited by applicant]
US 20120144551A1 · Guldalian · 2012 [cited by applicant]
US 20120150008A1 · Kaib et al. · 2012 [cited by applicant]
US 20120158075A1 · Kaib et al. · 2012 [cited by applicant]
US 20120191476A1 · Reid et al. · 2012 [cited by applicant]
US 20120265265A1 · Razavi et al. · 2012 [cited by applicant]
US 20120283794A1 · Kaib et al. · 2012 [cited by applicant]
US 20120293323A1 · Kaib et al. · 2012 [cited by applicant]
US 20120302860A1 · Volpe et al. · 2012 [cited by applicant]
US 20120310315A1 · Savage et al. · 2012 [cited by applicant]
US 20130041243A1 · Byrd et al. · 2013 [cited by applicant]
US 20130085538A1 · Volpe et al. · 2013 [cited by applicant]
US 20130144355A1 · Macho et al. · 2013 [cited by applicant]
US 20130231711A1 · Kaib · 2013 [cited by applicant]
US 20130245388A1 · Rafferty et al. · 2013 [cited by applicant]
US 20130274565A1 · Langer et al. · 2013 [cited by applicant]
US 20130317852A1 · Worrell et al. · 2013 [cited by applicant]
US 20130325078A1 · Whiting et al. · 2013 [cited by applicant]
US 20140012144A1 · Crone · 2014 [cited by applicant]
US 20140025131A1 · Sullivan et al. · 2014 [cited by applicant]
US 20140043149A1 · Cowan et al. · 2014 [cited by applicant]
US 20140046391A1 · Cowan et al. · 2014 [cited by applicant]
US 20140070957A1 · Longinotti-Buitoni et al. · 2014 [cited by applicant]
US 20140163663A1 · Poddar et al. · 2014 [cited by applicant]
US 20140324112A1 · Macho et al. · 2014 [cited by applicant]
US 20140378812A1 · Saroka et al. · 2014 [cited by applicant]
US 20150039053A1 · Kaib et al. · 2015 [cited by applicant]
US 20150161554A1 · Sweeney et al. · 2015 [cited by applicant]
US 20150297135A1 · Shoshani et al. · 2015 [cited by applicant]
US 20150328472A1 · Sullivan et al. · 2015 [cited by applicant]
US 20150331996A1 · Gustavson et al. · 2015 [cited by applicant]
US 20160004831A1 · Carlson et al. · 2016 [cited by applicant]
US 20160076175A1 · Rock et al. · 2016 [cited by applicant]
US 20160076176A1 · Rock et al. · 2016 [cited by applicant]
US 20160082277A1 · Foshee, Jr. et al. · 2016 [cited by applicant]
US 20160113581A1 · Amir et al. · 2016 [cited by applicant]
US 20160212103A1 · Rhoads et al. · 2016 [cited by applicant]
US 20160256104A1 · Romem et al. · 2016 [cited by applicant]
US 20160283900A1 · Johnson et al. · 2016 [cited by applicant]
US 20160286584A1 · Lee · 2016 [cited by applicant]
US 20160296114A1 · Finch et al. · 2016 [cited by applicant]
US 20170014073A1 · Shoshani et al. · 2017 [cited by applicant]
US 20170017454A1 · Kim et al. · 2017 [cited by applicant]
US 20170027469A1 · Amir et al. · 2017 [cited by applicant]
US 20170036066A1 · Chahine · 2017 [cited by applicant]
US 20170040758A1 · Amir et al. · 2017 [cited by applicant]
US 20170162840A1 · Pendry · 2017 [cited by applicant]
US 20170182330A1 · Schneider · 2017 [cited by examiner]
US 20170319862A1 · Foshee, Jr. et al. · 2017 [cited by applicant]
US 20170319865A1 · Stahmann et al. · 2017 [cited by applicant]
US 20170332931A1 · Szymkiewicz et al. · 2017 [cited by applicant]
US 20170367591A1 · Jorgensen · 2017 [cited by applicant]
US 20180116537A1 · Sullivan et al. · 2018 [cited by applicant]
US 20180117299A1 · Gustavson et al. · 2018 [cited by applicant]
US 20180184933A1 · Sullivan et al. · 2018 [cited by applicant]
US 20180185662A1 · Foshee, Jr. et al. · 2018 [cited by applicant]
US 20180243578A1 · Volosin · 2018 [cited by applicant]
US 20180275836A1 · Hermans et al. · 2018 [cited by applicant]
US 20180324486A1 · Lee et al. · 2018 [cited by applicant]
US 20180361165A1 · Jaax et al. · 2018 [cited by applicant]
US 20190015669A1 · Muessig et al. · 2019 [cited by applicant]
US 20190030350A1 · Finch et al. · 2019 [cited by applicant]
US 20190030352A1 · Sullivan et al. · 2019 [cited by applicant]
US 20190076666A1 · Medema · 2019 [cited by applicant]
US 20190116896A1 · Armour et al. · 2019 [cited by applicant]
US 20190269930A1 · Engman · 2019 [cited by examiner]
US 20190321650A1 · Raymond et al. · 2019 [cited by applicant]
DE 2005060985A2 · 2007 [cited by applicant]
DE 102018001251A1 · 2019 [cited by applicant]
EP 2305110A1 · 2011 [cited by applicant]
GB 2574000A · 2019 [cited by applicant]
GB 2577687A · 2020 [cited by applicant]
JP 4320257A · 2005 [cited by applicant]
JP 5963767A · 2014 [cited by applicant]
JP 2014526282A · 2014 [cited by applicant]
JP 201918003A · 2019 [cited by applicant]
TR 201809748A2 · 2023 [cited by applicant]
WO 9839061A2 · 1998 [cited by applicant]
WO 2011146448A1 · 2011 [cited by applicant]
WO 2012064604A1 · 2012 [cited by applicant]
WO 2012151160A1 · 2012 [cited by applicant]
WO 2015056262A1 · 2015 [cited by applicant]
Heartstart MRx and XL AED Algorithm—Application Note, Jul. 2001, Edition 2 Philips Healthcare, USA. [cited by applicant]
Klein, H. U., Goldenberg, I., and Moss, A. J., “Risk Stratification for Implantable Cardioverter Defibrillator Therapy: The Role of the Wearable Cardioverter-Defibrillator, Clinical update,” European Heart Journal, May … [cited by applicant]
Lifecor LifeVest System Model WCD 3100 Operator's Manual, 2006, PN 20B0040 Rev FI, Zoll Lifecor Corporation, Pittsburgh, PA. [cited by applicant]
LifeVest Model 4000 Patient Manual, Zoll, 2009, PN 20B0047 Rev B. [cited by applicant]
Pagan-Carlo, et al., “Encircling Overlapping Multipulse Shock Waveforms for Transthoracic Defibrillation,” JACC Journals, Dec. 1998, vol. 32 Issue 7, p. 2065-2071. [cited by applicant]
The LifeVest Network/Patient Data Management System, Zoll, 2015, 2000503 Rev A. [cited by applicant]
Zoll, LifeVest, Proven protection from Sudden Cardiac Death, issued Mar. 27, 2018, 4 pages. Pittsburgh PA, USA. [cited by applicant]
International Search Report and Written Opinion for PCT Application No. PCT/US2015/051726, dated May 20, 2016, European Patent Office, Rijswijk, 11 pages. [cited by applicant]
Office Action issued in corresponding Japanese Patent Application No. 2019-035091, filed Feb. 28, 2019, 5 pages. [cited by applicant]
JP Office Action dated Oct. 5, 2022, Japanese Patent Appln. No. 2019-35091 (with English translation) 16 pages total. [cited by applicant]
European Notice of Intent to Grant received in European Application No. 19 160 041.0-1126 with a mailing date of Mar. 16, 2023; 65 pages total. [cited by applicant]
Japanese Office Action with English translation dated Apr. 26, 2022; 14 pages total. [cited by applicant]
Office Action for Japanese Application No. 2019-35091, dated Nov. 24, 2020, 08 Pages (4 Pages of Official Copy and 4 Pages of English Translation). [cited by applicant]
Partial Search Report for European Application No. 19160041.0 , dated Aug. 7, 2019 (7 Pages). [cited by applicant]